TABLE 4

Effect of preincubation with CsA on the inhibition of OATP1B1-mediated uptake of [3H]E2G, [3H]E1S, [3H]BSP, pitavastatin, and atorvastatin

The inhibitory effect of CsA on OATP1B1-mediated uptake of [3H]E2G (0.1 µM), [3H]E1S (0.01 µM), [3H]BSP (0.01 µM), pitavastatin (0.1 µM), and atorvastatin (0.1 µM) was examined in the absence and presence of 1-hour preincubation with or without CsA as shown in Fig. 4. The IC50 values were estimated by a nonlinear least-squares regression analysis (mean ± S.D., n = 3). The R values of CsA were calculated by eqs. 5 and 6 with the exception that IC50 values instead of Ki values were used for the calculations because the applicability of eq. 4 to preincubation-dependent inhibition by CsA remains to be established.

SubstratesNo PreincubationaAfter 1-Hour Preincubation without CsAbAfter 1-Hour Preincubation with CsAc
IC50 of CsAR Value (= 1+[I]/IC50)dIC50 of CsAR Value (= 1+[I]/IC50)dIC50 of CsAR Value (= 1+[I]/IC50)d
[I] = Cmax[I] = [I]u,inlet,max[I] = Cmax[I] = [I]u,inlet,max[I] = Cmax[I] = [I]u,inlet,max
μMμMμM
E2G0.0620 ± 0.014216.320.40.0458 ± 0.004121.727.20.0139 ± 0.006669.387.3
E1S0.253 ± 0.0884.755.740.134 ± 0.0178.099.960.0264 ± 0.008537.046.5
BSP0.283 ± 0.0704.365.240.252 ± 0.0574.775.760.0799 ± 0.027312.916.0
Pitavastatin0.144 ± 0.0157.609.330.102 ± 0.03710.312.80.0263 ± 0.004037.146.6
Atorvastatin0.176 ± 0.0186.407.820.112 ± 0.0289.4811.70.0259 ± 0.003737.747.3
  • a Cells were coincubated with a substrate and CsA (0.01–10 µM) for 1 ([3H]E1S and atorvastatin), 2 (pitavastatin), or 5 minutes ([3H]E2G and [3H]BSP).

  • b Cells were coincubated with a substrate and CsA (0.01–10 µM) for 1 ([3H]E1S and atorvastatin), 2 (pitavastatin), or 5 minutes ([3H]E2G and [3H]BSP) after 1-hour preincubation with KH buffer without CsA.

  • c Cells were coincubated with a substrate and CsA (0.001–1 µM) for 1 ([3H]E1S and atorvastatin), 2 (pitavastatin), or 5 minutes ([3H]E2G and [3H]BSP) after 1-hour preincubation with KH buffer containing CsA (0.001–1 µM).

  • d R values that were calculated based on 200-mg dose of CsA are presented.